Multicenter evaluation of the accelerate PhenoTest BC kit for rapid identification and phenotypic antimicrobial susceptibility testing using morphokinetic cellular analysis

Journal of Clinical Microbiology

Volumn 56, Issue 4, 2018, Pages

  Pancholi, Preeti ^a   Carroll, Karen C ^b   Buchan, Blake W ^c   Chan, Raymond C ^d   Dhiman, Neelam ^e   Ford, Bradley ^f   Granato, Paul A ^g   Harrington, Amanda T ^h   Hernandez, Diana R ⁱ   Humphries, Romney M ^j   Jindra, Matthew R ^a   Ledeboer, Nathan A ^c   Miller, Shelley A ^j   Brian Mochon, A ^k   Morgan, Margie A ^d   Patel, Robin ^l   Schreckenberger, Paul C ^h   Stamper, Paul D ^m   Simner, Patricia J ^b   Tucci, Nancy E ^g   Zimmerman, Cynthia ^m   Wolk, Donna M ⁱ   more..

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

^e Med Fusion   (United States)

^f UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^g Laboratory Alliance of Central New York   (United States)

^h LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

ⁱ Geisinger Center for Health   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k BANNER HEALTH   (United States)

^l MAYO CLINIC   (United States)

^m MRIGlobal   (United States)

more..

Author keywords

Antimicrobial susceptibility testing; Bacteremia; Blood culture; Candidemia; FISH; Identification; MIC; Morphokinetic cellular analysis; Phenotypic; rapid

Indexed keywords

AMIKACIN; AMPICILLIN; AZTREONAM; CEFAZOLIN; CEFEPIME; CEFOXITIN; CEFTAROLINE; CEFTAZIDIME; CEFTRIAXONE; COLISTIN; COTRIMOXAZOLE; DAPTOMYCIN; DOXYCYCLINE; ERTAPENEM; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; MEROPENEM; MINOCYCLINE; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TOBRAMYCIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BROTH DILUTION; CANDIDA ALBICANS; CANDIDA GLABRATA; CITROBACTER; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DISK DIFFUSION; ENTEROBACTER; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; FUNGUS IDENTIFICATION; INTERMETHOD COMPARISON; KLEBSIELLA; MEASUREMENT ACCURACY; MEASUREMENT ERROR; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL IDENTIFICATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEUS; PSEUDOMONAS AERUGINOSA; SENSITIVITY ANALYSIS; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS LUGDUNENSIS; STREPTOCOCCUS; BLOOD; BLOOD CULTURE; CLINICAL TRIAL; DEVICES; DIAGNOSTIC KIT; DRUG EFFECT; EVALUATION STUDY; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; GRAM POSITIVE BACTERIUM; GRAM POSITIVE INFECTION; HUMAN; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTICENTER STUDY; PROCEDURES; STATISTICS AND NUMERICAL DATA;

ANTI-BACTERIAL AGENTS; BLOOD CULTURE; DISK DIFFUSION ANTIMICROBIAL TESTS; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; REAGENT KITS, DIAGNOSTIC; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 85044779516     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01329-17     Document Type: Article

References (73)

1. Sutton JP, Friedman B. 2006. Trends in septicemia hospitalizations and readmissions in selected HCUP states, 2005 and 2010. Statistical Brief #161. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Agency for Healthcare Research and Quality, US Department of Health and Human Services, Rockville, MD.
2. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M. 2006. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589–1596. https://doi.org/10.1097/01.CCM.0000217961.75225.E9.
3. Buehler SS, Madison B, Snyder SR, Derzon JH, Cornish NE, Saubolle MA, Weissfeld AS, Weinstein MP, Liebow EB, Wolk DM. 2016. Effectiveness of practices to increase timeliness of providing targeted therapy for inpatients with bloodstream infections: a laboratory medicine best practices systematic review and meta-analysis. Clin Microbiol Rev 29:59–103. https://doi.org/10.1128/CMR.00053-14.
4. Retamar P, Portillo MM, Lopez-Prieto MD, Rodriguez-Lopez F, de Cueto M, Garcia MV, Gomez MJ, Del Arco A, Munoz A, Sanchez-Porto A, Torres-Tortosa M, Martin-Aspas A, Arroyo A, Garcia-Figueras C, Acosta F, Corzo JE, Leon-Ruiz L, Escobar-Lara T, Rodriguez-Bano J, SAEI/SAMPAC Bacteremia Group. 2012. Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis. Antimicrob Agents Chemother 56:472–478. https://doi.org/10.1128/AAC.00462-11.
5. Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, et al. 2017. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med 45:486–552. https://doi.org/10.1097/CCM.0000000000002255.
6. van Belkum A, Dunne WM, Jr. 2013. Next-generation antimicrobial susceptibility testing. J Clin Microbiol 51:2018–2024. https://doi.org/10.1128/JCM.00313-13.
7. Bauer KA, West JE, Balada-Llasat JM, Pancholi P, Stevenson KB, Goff DA. 2010. An antimicrobial stewardship program’s impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. Clin Infect Dis 51:1074–1080. https://doi.org/10.1086/656623.
8. Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW. 2005. Bloodstream infections caused by antibiotic-resistant Gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 49:760–766. https://doi.org/10.1128/AAC.49.2.760-766.2005.
9. Micek ST, Lloyd AE, Ritchie DJ, Reichley RM, Fraser VJ, Kollef MH. 2005. Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother 49:1306–1311. https://doi.org/10.1128/AAC.49.4.1306-1311.2005.
10. Cheong HS, Kang CI, Wi YM, Ko KS, Chung DR, Lee NY, Song JH, Peck KR. 2008. Inappropriate initial antimicrobial therapy as a risk factor for mortality in patients with community-onset Pseudomonas aeruginosa bacteraemia. Eur J Clin Microbiol Infect Dis 27:1219–1225. https://doi.org/10.1007/s10096-008-0568-5.
11. R blood culture identification panel with antimicrobial treatment recommendations for bloodstream infections at a midwestern academic tertiary hospital. Diagn Microbiol Infect Dis 81:96 –101. https://doi.org/10.1016/j.diagmicrobio.2014.11.004.
12. Ledeboer NA, Lopansri BK, Dhiman N, Cavagnolo R, Carroll KC, Granato P, Thomson R, Jr, Butler-Wu SM, Berger H, Samuel L, Pancholi P, Swyers L, Hansen GT, Tran NK, Polage CR, Thomson KS, Hanson ND, Winegar R, Buchan BW. 2015. Identification of Gram-negative bacteria and genetic resistance determinants from positive blood culture broths by use of the Verigene Gram-negative blood culture multiplex microarray-based molecular assay. J Clin Microbiol 53:2460 –2472. https://doi.org/10.1128/JCM.00581-15.
13. Liesenfeld O, Lehman L, Hunfeld KP, Kost G. 2014. Molecular diagnosis of sepsis: new aspects and recent developments. Eur J Microbiol Immunol (Bp) 4:1–25. https://doi.org/10.1556/EuJMI.4.2014.1.1.
14. Accelerate Diagnostics, Inc. 2017. Accelerate PhenoTest™ BC kit instructions for use. Accelerate Diagnostics, Inc., Tucson, AZ.
15. Agresti A, Coull BA. 1998. Approximate is better than “exact” for interval estimation of binomial proportions. Am Stat 52:119–126. https://doi.org/10.2307/2685469.
16. Newcombe RG. 2001. Logit confidence intervals and the inverse sinh transformation. Am Stat 55:200–202. https://doi.org/10.1198/000313001317098167.
17. Brown LD, Cai TT, DasGupta A. 2001. Interval estimation for a binomial proportion (with discussion). Stat Sci 16:101–133. https://doi.org/10.1214/ss/1009213286.
18. Glockner A, Karthaus M. 2011. Current aspects of invasive candidiasis and aspergillosis in adult intensive care patients. Mycoses 54:420–433. https://doi.org/10.1111/j.1439-0507.2010.01885.x.
19. Karthaus M, Cornely OA. 2007. Treatment options in candidaemia. Mycoses 50(Suppl 1):S44–S49. https://doi.org/10.1111/j.1439-0507.2007.01379.x.
20. Klepser ME. 2006. Candida resistance and its clinical relevance. Pharma-cotherapy 26:68S–75S. https://doi.org/10.1592/phco.26.6part2.68S.
21. Salgado CD. 2008. The risk of developing a vancomycin-resistant Enterococcus bloodstream infection for colonized patients. Am J Infect Control 36:S175.e5–S175.e8. https://doi.org/10.1016/j.ajic.2008.10.010.
22. Sievert DM, Rudrik JT, Patel JB, McDonald LC, Wilkins MJ, Hageman JC. 2008. Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. Clin Infect Dis 46:668–674. https://doi.org/10.1086/527392.
23. Maaroufi Y, Heymans C, De Bruyne JM, Duchateau V, Rodriguez-Villalobos H, Aoun M, Crokaert F. 2003. Rapid detection of Candida albicans in clinical blood samples by using a TaqMan-based PCR assay. J Clin Microbiol 41:3293–3298. https://doi.org/10.1128/JCM.41.7.3293-3298.2003.
24. Altun O, Almuhayawi M, Ullberg M, Ozenci V. 2013. Clinical evaluation of the FilmArray blood culture identification panel in identification of bacteria and yeasts from positive blood culture bottles. J Clin Microbiol 51:4130–4136. https://doi.org/10.1128/JCM.01835-13.
25. Donner LM, Campbell WS, Lyden E, Van Schooneveld TC. 2017. Assessment of rapid-blood-culture-identification result interpretation and antibiotic prescribing practices. J Clin Microbiol 55:1496–1507. https://doi.org/10.1128/JCM.02395-16.
26. Messacar K, Hurst AL, Child J, Campbell K, Palmer C, Hamilton S, Dowell E, Robinson CC, Parker SK, Dominguez SR. 2017. Clinical impact and provider acceptability of real-time antimicrobial stewardship decision support for rapid diagnostics in children with positive blood culture results. J Pediatric Infect Dis Soc 6:267–274. https://doi.org/10.1093/jpids/piw047.
27. Forrest GN, Mankes K, Jabra-Rizk MA, Weekes E, Johnson JK, Lincalis DP, Venezia RA. 2006. Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs. J Clin Microbiol 44:3381–3383. https://doi.org/10.1128/JCM.00751-06.
28. Forrest GN, Mehta S, Weekes E, Lincalis DP, Johnson JK, Venezia RA. 2006. Impact of rapid in situ hybridization testing on coagulase-negative staphylococci positive blood cultures. J Antimicrob Chemother 58: 154 –158. https://doi.org/10.1093/jac/dkl146.
29. Forrest GN, Roghmann MC, Toombs LS, Johnson JK, Weekes E, Lincalis DP, Venezia RA. 2008. Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy. Antimicrob Agents Chemother 52: 3558–3563. https://doi.org/10.1128/AAC.00283-08.
30. Haigh JD, Green IM, Ball D, Eydmann M, Millar M, Wilks M. 2013. Rapid identification of bacteria from bioMerieux BacT/ALERT blood culture bottles by MALDI-TOF MS. Br J Biomed Sci 70:149–155. https://doi.org/10.1080/09674845.2013.11669949.
31. Klein S, Zimmermann S, Kohler C, Mischnik A, Alle W, Bode KA. 2012. Integration of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in blood culture diagnostics: a fast and effective approach. J Med Microbiol 61:323–331. https://doi.org/10.1099/jmm.0.035550-0.
32. Lagace-Wiens PR, Adam HJ, Karlowsky JA, Nichol KA, Pang PF, Guenther J, Webb AA, Miller C, Alfa MJ. 2012. Identification of blood culture isolates directly from positive blood cultures by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry and a commercial extraction system: analysis of performance, cost, and turnaround time. J Clin Microbiol 50:3324–3328. https://doi.org/10.1128/JCM.01479-12.
33. Rand KH, Delano JP. 2014. Direct identification of bacteria in positive blood cultures: comparison of two rapid methods, FilmArray and mass spectrometry. Diagn Microbiol Infect Dis 79:293–297. https://doi.org/10.1016/j.diagmicrobio.2014.03.014.
34. R diagnostic blood culture systems. J Appl Microbiol 116:934–941. https://doi.org/10.1111/jam.12434.
35. Chapin K, Musgnug M. 2003. Evaluation of three rapid methods for the direct identification of Staphylococcus aureus from positive blood cultures. J Clin Microbiol 41:4324–4327. https://doi.org/10.1128/JCM.41.9.4324-4327.2003.
36. Gonzalez V, Padilla E, Gimenez M, Vilaplana C, Perez A, Fernandez G, Quesada MD, Pallares MA, Ausina V. 2004. Rapid diagnosis of Staphylococcus aureus bacteremia using S. aureus PNA FISH. Eur J Clin Microbiol Infect Dis 23:396–398. https://doi.org/10.1007/s10096-004-1112-x.
37. Hartmann H, Stender H, Schafer A, Autenrieth IB, Kempf VA. 2005. Rapid identification of Staphylococcus aureus in blood cultures by a combination of fluorescence in situ hybridization using peptide nucleic acid probes and flow cytometry. J Clin Microbiol 43:4855–4857. https://doi.org/10.1128/JCM.43.9.4855-4857.2005.
38. Hensley DM, Tapia R, Encina Y. 2009. An evaluation of the advandx Staphylococcus aureus/CNS PNA FISH assay. Clin Lab Sci 22:30–33.
39. Holtzman C, Whitney D, Barlam T, Miller NS. 2011. Assessment of impact of peptide nucleic acid fluorescence in situ hybridization for rapid identification of coagulase-negative staphylococci in the absence of antimicrobial stewardship intervention. J Clin Microbiol 49:1581–1582. https://doi.org/10.1128/JCM.02461-10.
40. Ly T, Gulia J, Pyrgos V, Waga M, Shoham S. 2008. Impact upon clinical outcomes of translation of PNA FISH-generated laboratory data from the clinical microbiology bench to bedside in real time. Ther Clin Risk Manag 4:637– 640. https://doi.org/10.2147/TCRM.S2838.
41. Morgan MA, Marlowe E, Novak-Weekly S, Miller JM, Painter TM, Salimnia H, Crystal B. 2011. A 1.5 hour procedure for identification of Enterococcus species directly from blood cultures. J Vis Exp 2011:e2616.
42. Sogaard M, Hansen DS, Fiandaca MJ, Stender H, Schonheyder HC. 2007. Peptide nucleic acid fluorescence in situ hybridization for rapid detection of Klebsiella pneumoniae from positive blood cultures. J Med Microbiol 56:914–917. https://doi.org/10.1099/jmm.0.46829-0.
43. Wilson DA, Joyce MJ, Hall LS, Reller LB, Roberts GD, Hall GS, Alexander BD, Procop GW. 2005. Multicenter evaluation of a Candida albicans peptide nucleic acid fluorescent in situ hybridization probe for characterization of yeast isolates from blood cultures. J Clin Microbiol 43: 2909–2912. https://doi.org/10.1128/JCM.43.6.2909-2912.2005.
44. Kollef MH, Zilberberg MD, Shorr AF, Vo L, Schein J, Micek ST, Kim M. 2011. Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: a multicenter cohort study. J Infect 62:130–135. https://doi.org/10.1016/j.jinf.2010.12.009.
45. Sligl WI, Dragan T, Smith SW. 2015. Nosocomial Gram-negative bacteremia in intensive care: epidemiology, antimicrobial susceptibilities, and outcomes. Int J Infect Dis 37:129–134. https://doi.org/10.1016/j.ijid.2015.06.024.
46. Wisplinghoff H, Ebbers J, Geurtz L, Stefanik D, Major Y, Edmond MB, Wenzel RP, Seifert H. 2014. Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities. Int J Antimicrob Agents 43:78–81. https://doi.org/10.1016/j.ijantimicag.2013.09.005.
47. Wisplinghoff H, Seifert H, Tallent SM, Bischoff T, Wenzel RP, Edmond MB. 2003. Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities. Pe-diatr Infect Dis J 22:686–691. https://doi.org/10.1097/01.inf.0000078159.53132.40.
48. Huang AM, Newton D, Kunapuli A, Gandhi TN, Washer LL, Isip J, Collins CD, Nagel JL. 2013. Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia. Clin Infect Dis 57:1237–1245. https://doi.org/10.1093/cid/cit498.
49. Salimnia H, Fairfax MR, Lephart P, Morgan M, Gilbreath JJ, Butler-Wu SM, Templeton KE, Hamilton FJ, Wu F, Buckner R, Fuller D, Davis TE, Abdel-hamed AM, Jacobs MR, Miller A, Pfrommer B, Carroll KC. 2014. An international, prospective, multicenter evaluation of the combination of AdvanDx Staphylococcus QuickFISH BC with mecA XpressFISH for detection of methicillin-resistant Staphylococcus aureus isolates from positive blood cultures. J Clin Microbiol 52:3928–3932. https://doi.org/10.1128/JCM.01811-14.
50. Holubar M, Meng L, Deresinski S. 2016. Bacteremia due to methicillin-resistant Staphylococcus aureus: new therapeutic approaches. Infect Dis Clin North Am 30:491–507. https://doi.org/10.1016/j.idc.2016.02.009.
51. Moise PA, Culshaw DL, Wong-Beringer A, Bensman J, Lamp KC, Smith WJ, Bauer K, Goff DA, Adamson R, Leuthner K, Virata MD, McKinnell JA, Chaudhry SB, Eskandarian R, Lodise T, Reyes K, Zervos MJ. 2016. Comparative effectiveness of vancomycin versus daptomycin for MRSA bacteremia with vancomycin MIC 1 mg/L: a multicenter evaluation. Clin Ther 38:16–30. https://doi.org/10.1016/j.clinthera.2015.09.017.
52. Falagas ME, Tansarli GS, Rafailidis PI, Kapaskelis A, Vardakas KZ. 2012. Impact of antibiotic MIC on infection outcome in patients with susceptible Gram-negative bacteria: a systematic review and meta-analysis. Antimicrob Agents Chemother 56:4214–4222. https://doi.org/10.1128/AAC.00663-12.
53. Clinical and Laboratory Standards Institute. 2016. Performance standards for antimicrobial susceptibility testing, 26th ed. CLSI supplement M100S. Clinical and Laboratory Standards Institute, Wayne, PA.
54. Yonetani S, Okazaki M, Araki K, Makino H, Fukugawa Y, Okuyama T, Ohnishi H, Watanabe T. 2012. Direct inoculation method using BacT/ ALERT 3D and BD Phoenix System allows rapid and accurate identification and susceptibility testing for both Gram-positive cocci and Gram-negative rods in aerobic blood cultures. Diagn Microbiol Infect Dis 73:129–134. https://doi.org/10.1016/j.diagmicrobio.2012.03.004.
55. Romero-Gomez MP, Gomez-Gil R, Pano-Pardo JR, Mingorance J. 2012. Identification and susceptibility testing of microorganism by direct inoculation from positive blood culture bottles by combining MALDI-TOF and Vitek-2 Compact is rapid and effective. J Infect 65:513–520. https://doi.org/10.1016/j.jinf.2012.08.013.
56. Gherardi G, Angeletti S, Panitti M, Pompilio A, Di Bonaventura G, Crea F, Avola A, Fico L, Palazzo C, Sapia GF, Visaggio D, Dicuonzo G. 2012. Comparative evaluation of the Vitek-2 Compact and Phoenix systems for rapid identification and antibiotic susceptibility testing directly from blood cultures of Gram-negative and Gram-positive isolates. Diagn Microbiol Infect Dis 72:20 –31. https://doi.org/10.1016/j.diagmicrobio.2011.09.015.
57. Hazelton B, Thomas LC, Olma T, Kok J, O’Sullivan M, Chen SC, Iredell JR. 2014. Rapid and accurate direct antibiotic susceptibility testing of blood culture broths using MALDI Sepsityper combined with the BD Phoenix automated system. J Med Microbiol 63:1590–1594. https://doi.org/10.1099/jmm.0.075580-0.
58. Nilsen E. 2012. Automated identification and susceptibility determination directly from blood cultures facilitates early targeted antibiotic therapy. Scand J Infect Dis 44:860–865. https://doi.org/10.3109/00365548.2012.689848.
59. Munoz-Davila MJ, Yague G, Albert M, Garcia-Lucas T. 2012. Comparative evaluation of Vitek 2 identification and susceptibility testing of Gram-negative rods directly and isolated from BacT/ALERT-positive blood culture bottles. Eur J Clin Microbiol Infect Dis 31:663–669. https://doi.org/10.1007/s10096-011-1356-1.
60. Marschal M, Bachmaier J, Autenrieth I, Oberhettinger P, Willmann M, Peter S. 2017. Evaluation of the Accelerate Pheno system for fast identification and antimicrobial susceptibility testing from positive blood culture in Gram-negative bloodstream infection. J Clin Microbiol 55: 2116–2126. https://doi.org/10.1128/JCM.00181-17.
61. Brazelton de Cárdenas JN, Su Y, Rodriguez A, Hewitt C, Tang L, Garner CD, Hayden RT. 2017. Evaluation of rapid phenotypic identification and antimicrobial susceptibility testing in a pediatric oncology center. Diagn Microbiol Infect Dis 89:52–57. https://doi.org/10.1016/j.diagmicrobio.2017.06.014.
62. Vourli S, Dafopoulou K, Vrioni G, Tsakris A, Pournaras S. 2017. Evaluation of two automated systems for colistin susceptibility testing of carbapenem-resistant Acinetobacter baumannii clinical isolates. J Antimicrob Chemother 72:2528–2530. https://doi.org/10.1093/jac/dkx186.
63. Dafopoulou K, Zarkotou O, Dimitroulia E, Hadjichristodoulou C, Genni-mata V, Pournaras S, Tsakris A. 2015. Comparative evaluation of colistin susceptibility testing methods among carbapenem-nonsusceptible Klebsiella pneumoniae and Acinetobacter baumannii clinical isolates. Antimicrob Agents Chemother 59:4625–4630. https://doi.org/10.1128/AAC.00868-15.
64. Sisirak M, Hukic M. 2012. Acinetobacter baumannii as a cause of sepsis. Med Glas (Zenica) 9:311–316.
65. Ng TM, Khong WX, Harris PN, De PP, Chow A, Tambyah PA, Lye DC. 2016. Empiric piperacillin-tazobactam versus carbapenems in the treatment of bacteraemia due to extended-spectrum beta-lactamase-producing Enterobacteriaceae. PLoS One 11:e0153696. https://doi.org/10.1371/journal.pone.0153696.
66. Wenzler E, Goff DA, Humphries R, Goldstein EJC. 2017. Anticipating the unpredictable: a review of antimicrobial stewardship and Acinetobacter infections. Infect Dis Ther 6:149–172. https://doi.org/10.1007/s40121-017-0149-y.
67. Wang P, Bowler SL, Kantz SF, Mettus RT, Guo Y, McElheny CL, Doi Y. 2016. Comparison of minocycline susceptibility testing methods for carbapenem-resistant Acinetobacter baumannii. J Clin Microbiol 54: 2937–2941. https://doi.org/10.1128/JCM.01810-16.
68. Bobenchik AM, Deak E, Hindler JA, Charlton CL, Humphries RM. 2017. Performance of Vitek 2 for antimicrobial susceptibility testing of Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomo-nas maltophilia with Vitek 2 (2009 FDA) and CLSI M100S 26th edition breakpoints. J Clin Microbiol 55:450–456. https://doi.org/10.1128/JCM.01859-16.
69. Calvo J, Cano ME, Pitart C, Marco F, Rodriguez-Martinez JM, Pascual A, Martinez-Martinez L. 2011. Evaluation of three automated systems for susceptibility testing of enterobacteria containing qnrB, qnrS, and/or aac(6=)-Ib-cr. J Clin Microbiol 49:3343–3345. https://doi.org/10.1128/JCM.00563-11.
70. Arena F, Giani T, Vaggelli G, Terenzi G, Pecile P, Rossolini GM. 2015. Accuracy of different methods for susceptibility testing of gentamicin with KPC carbapenemase-producing Klebsiella pneumoniae. Diagn Microbiol Infect Dis 81:132–134. https://doi.org/10.1016/j.diagmicrobio.2014.10.011.
71. Morency-Potvin P, Schwartz DN, Weinstein RA. 2017. Antimicrobial stewardship: how the microbiology laboratory can right the ship. Clin Microbiol Rev 30:381–407. https://doi.org/10.1128/CMR.00066-16.
72. Timbrook TT, Morton JB, McConeghy KW, Caffrey AR, Mylonakis E, LaPlante KL. 2017. The effect of molecular rapid diagnostic testing on clinical outcomes in bloodstream infections: a systematic review and meta-analysis. Clin Infect Dis 64:15–23. https://doi.org/10.1093/cid/ciw649.
73. Carroll KC. 2017. Biographical Feature: Paul C. Schreckenberger, Ph.D. J Clin Microbiol 55:2298–2303. https://doi.org/10.1128/JCM.00843-17.